Diesel Exhaust Inhalation Causes Vascular Dysfunction and Impaired Endogenous Fibrinolysis
-
- Nicholas L. Mills
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
-
- Håkan Törnqvist
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
-
- Simon D. Robinson
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
-
- Manuel Gonzalez
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
-
- Kareen Darnley
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
-
- William MacNee
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
-
- Nicholas A. Boon
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
-
- Ken Donaldson
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
-
- Anders Blomberg
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
-
- Thomas Sandstrom
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
-
- David E. Newby
- From the Centre for Cardiovascular Science (N.L.M., S.D.R., N.A.B., D.E.N.), Edinburgh University, Edinburgh, Scotland; the Department of Respiratory Medicine and Allergy (H.T., M.G., A.B., T.S.), Umeå University, Umeå, Sweden; and the Wellcome Trust Clinical Research Facility (K. Darnley) and ELEGI Colt Laboratory (W.M., K. Donaldson), Centre for Inflammation Research, Edinburgh University, Edinburgh, Scotland.
抄録
<jats:p> <jats:bold> <jats:italic>Background—</jats:italic> </jats:bold> Although the mechanisms are unknown, it has been suggested that transient exposure to traffic-derived air pollution may be a trigger for acute myocardial infarction. The study aim was to investigate the effects of diesel exhaust inhalation on vascular and endothelial function in humans. </jats:p> <jats:p> <jats:bold> <jats:italic>Methods and Results—</jats:italic> </jats:bold> In a double-blind, randomized, cross-over study, 30 healthy men were exposed to diluted diesel exhaust (300 μg/m <jats:sup>3</jats:sup> particulate concentration) or air for 1 hour during intermittent exercise. Bilateral forearm blood flow and inflammatory factors were measured before and during unilateral intrabrachial bradykinin (100 to 1000 pmol/min), acetylcholine (5 to 20 μg/min), sodium nitroprusside (2 to 8 μg/min), and verapamil (10 to 100 μg/min) infusions 2 and 6 hours after exposure. There were no differences in resting forearm blood flow or inflammatory markers after exposure to diesel exhaust or air. Although there was a dose-dependent increase in blood flow with each vasodilator ( <jats:italic>P</jats:italic> <0.0001 for all), this response was attenuated with bradykinin ( <jats:italic>P</jats:italic> <0.05), acetylcholine ( <jats:italic>P</jats:italic> <0.05), and sodium nitroprusside ( <jats:italic>P</jats:italic> <0.001) infusions 2 hours after exposure to diesel exhaust, which persisted at 6 hours. Bradykinin caused a dose-dependent increase in plasma tissue plasminogen activator ( <jats:italic>P</jats:italic> <0.0001) that was suppressed 6 hours after exposure to diesel ( <jats:italic>P</jats:italic> <0.001; area under the curve decreased by 34%). </jats:p> <jats:p> <jats:bold> <jats:italic>Conclusions—</jats:italic> </jats:bold> At levels encountered in an urban environment, inhalation of dilute diesel exhaust impairs 2 important and complementary aspects of vascular function in humans: the regulation of vascular tone and endogenous fibrinolysis. These important findings provide a potential mechanism that links air pollution to the pathogenesis of atherothrombosis and acute myocardial infarction. </jats:p>
収録刊行物
-
- Circulation
-
Circulation 112 (25), 3930-3936, 2005-12-20
Ovid Technologies (Wolters Kluwer Health)